Status:
UNKNOWN
Changes in Serum, Follicular Fluid SREBP1c and LRG1 Levels in PCOS Patients and Correlation With Insulin Resistance
Lead Sponsor:
Gui Xiaoting
Conditions:
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Eligibility:
FEMALE
20-50 years
Brief Summary
Polycystic ovary syndrome (PCOS) is a common reproductive endocrine and metabolic disease that affects 6-20% of women of childbearing age worldwide. Due to changes in modern lifestyles such as low fib...
Detailed Description
1. The diagnostic criteria for all participants with polycystic ovary syndrome included in the study were based on the 2003 European Society for Human Reproductive and Embryonic Medicine and American ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Polycystic Ovary Syndrome
Exclusion
- Congenital adrenal cortical hyperplasia Adrenocortical carcinoma Cushing syndrome.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06066034
Start Date
April 1 2022
End Date
April 30 2024
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China, 563000